Mental disorder
Therapeutic area
Psychiatry
Rare disease
No
- Definition
- A disease that has its basis in the disruption of mental process.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Mental disorder
- Therapeutic area
- Psychiatry
- mental disorder
- disorder of mental process
- mental or behavioral disorder
- mental or behavioural disorder
- mental process disease
- Severity
- Mild
- Neurology
- Psychiatry
- MONDO ID
- MONDO:0005084
- Parent condition
- MONDO:0002025
Related records
Broader conditions (8)
- Brain disorder
- Central nervous system disorder
- Disease
- Disease by body system or component
- Disease by developmental or physiological process
- Human disease
- Nervous system disorder
- Psychiatric disorder
Narrower conditions (162)
- Acute stress disorder
- Adjustment disorder
- Agoraphobia
- Agraphia
- AIDS phobia
- Alcohol withdrawal delirium
- Alcohol-induced mental disorder
- Alcohol-related birth defect
- Alcoholic psychosis
- Alexia
- Animal phobia
- Anxiety
- Anxiety disorder
- Aphasia
- Articulation disorder
- Attention deficit hyperactivity disorder, inattentive type
- Attention deficit-hyperactivity disorder
- Attention deficit-hyperactivity disorder 8
- Atypical autism
- Atypical depressive disorder
Trials (1,752)
- "Art Therapy" in Acute Psychiatry
- "Breathlessness Diagnostics in a Box" (BiaB) for Primary Care. A Multi-country Quality Improvement Project Using a Randomized Stepped-wedge Design
- "CoMBI-SMI Multicenter Study: A Person-Centered Cognitive-Behavioral Intervention for Severe Mental Illness"
- "Let's Get Organized" in Adult Psychiatric/habilitation Care
- "MenPhys: Intervention Protocol for Physical Wellness in Mental Health"
- "Pilot Study of Music Intervention for Recovery of People With Severe Mental Disorder in the Community"
- "Recovery 4 US" - A Photovoice-based Social Media Program
- 15 Year Follow-up of New Beginnings Program for Divorced Families
- 3-year Follow-up of the Mind My Mind RCT
- A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
- A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
- A 6-Month Efficacy and Safety Study of Org 50081 in Adult Patients With Chronic Primary Insomnia (21106/P05701/MK-8265-002)
- A Behavioral Intervention to Improve Work Outcomes
- A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
- A Brief Case Management Intervention for People Involuntarily Admitted to a Psychiatric Hospital
- A Brief Case Management Intervention to Promote Personal Recovery and Prevent Psychiatric Involuntary Readmissions.
- A Brief Mindfulness-Based Intervention for Suicidal Ideation
- A Clinical Study to Map the HLA Genomic Region in the Greek Population
- A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression
- A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
Approved drugs (12)
- Bremelanotide acetate
- Chlorpromazine
- Diazepam
- Flibanserin
- Fluphenazine hydrochloride
- Haloperidol
- Loxapine
- Olanzapine
- Oxazepam
- Paliperidone
- Trifluoperazine hydrochloride
- Ziprasidone hydrochloride
Drugs in development (40)
- ABT-925 Phase 2
- Acetylcysteine Phase 2
- Amantadine Phase 1
- Amantadine hydrochloride Phase 1
- Aripiprazole Phase 3
- Berupipam Phase 1
- Brexpiprazole Phase 3
- Cannabidiol Phase 2
- Dexmedetomidine Phase 2
- Divalproex sodium Phase 1
- Drinabant Phase 2
- Dronabinol Early phase 1
- Elopiprazole Phase 1
- Galantamine hydrobromide Phase 3
- Gepirone Phase 2
- Gevotroline Phase 1
- Glycine Phase 2
- GTS-21 Phase 1
- Iomazenil Early phase 1
- Ketamine Phase 1
Other linked drugs (11)
- Amisulpride
- Anpocogin
- Chlorprothixene
- Dihydrexidine
- Fluphenazine
- Ibuprofen
- Levomepromazine
- Paroxetine
- Perazine
- Perospirone
- Triflupromazine